|
Volumn 130, Issue 3, 1994, Pages 366-375
|
Efficacy and safety of oral cyclosporin A (CyA; Sandimmun®) for long‐term treatment of chronic severe plaque psoriasis
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CYCLOSPORIN A;
ADULT;
AGED;
ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
FEMALE;
HEADACHE;
HIRSUTISM;
HUMAN;
HYPERTENSION;
MAJOR CLINICAL STUDY;
MALE;
MULTICENTER STUDY;
NEPHROTOXICITY;
ORAL DRUG ADMINISTRATION;
PRIORITY JOURNAL;
PSORIASIS;
RANDOMIZED CONTROLLED TRIAL;
ADMINISTRATION, ORAL;
ADOLESCENT;
ADULT;
AGED;
CHRONIC DISEASE;
CREATININE;
CYCLOSPORINE;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG ADMINISTRATION SCHEDULE;
FEMALE;
HUMANS;
HYPERTENSION;
KIDNEY DISEASES;
MALE;
MIDDLE AGED;
NEOPLASMS;
PSORIASIS;
REMISSION INDUCTION;
TREATMENT OUTCOME;
|
EID: 0028291307
PISSN: 00070963
EISSN: 13652133
Source Type: Journal
DOI: 10.1111/j.1365-2133.1994.tb02935.x Document Type: Article |
Times cited : (122)
|
References (14)
|